Details for Patent: 7,560,429
✉ Email this page to a colleague
Which drugs does patent 7,560,429 protect, and when does it expire?
Patent 7,560,429 protects NOCDURNA and is included in one NDA.
This patent has forty-three patent family members in twenty-nine countries.
Summary for Patent: 7,560,429
| Title: | Orodispersible dosage forms of desmopressin acetate |
| Abstract: | Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary nocturnal enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way. |
| Inventor(s): | Nilsson; Anders (Lund, SE), Lindner; Hans (Leichlingen, DE), Wittendorff; Jorgen (Hvidovre, DK) |
| Assignee: | Ferring B.V. (Hoofddorp, NL) |
| Application Number: | 10/513,437 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,560,429 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Dosage form; |
Drugs Protected by US Patent 7,560,429
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-001 | Jun 21, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ⤷ Try a Trial | |||
| Ferring Pharms Inc | NOCDURNA | desmopressin acetate | TABLET;SUBLINGUAL | 022517-002 | Jun 21, 2018 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,560,429
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0210397.6 | May 7, 2002 |
| PCT/IB02/04036 | Sep 20, 2002 | |
| PCT Information | |||
| PCT Filed | May 07, 2003 | PCT Application Number: | PCT/IB03/02368 |
| PCT Publication Date: | November 20, 2003 | PCT Publication Number: | WO03/094886 |
International Family Members for US Patent 7,560,429
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 039092 | ⤷ Try a Trial | |||
| Argentina | 039794 | ⤷ Try a Trial | |||
| Argentina | 107948 | ⤷ Try a Trial | |||
| Austria | 333886 | ⤷ Try a Trial | |||
| Australia | 2002337419 | ⤷ Try a Trial | |||
| Australia | 2003233118 | ⤷ Try a Trial | |||
| Australia | 2003299480 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
